Bolt Biotherapeutics (BOLT) Amortizatization of Intangibles (2020 - 2026)

Bolt Biotherapeutics has reported Amortizatization of Intangibles for 7 years, with the latest figure at $45000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 78.47% year-over-year to $45000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $506000.0 (down 71.75% YoY) and the FY2025 annual result came in at $670000.0, down 74.38% from the prior year.
• Amortizatization of Intangibles declined to $45000.0 in Q1 2026 per BOLT's latest filing, from $161000.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $1.3 million in Q3 2023 and troughed at -$466000.0 in Q1 2022.
• A 5-year average of $449352.9 and a median of $308000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles soared 3413.16% in 2023, then sank 79.77% in 2025.
• Over 5 years, Amortizatization of Intangibles stood at $471000.0 in 2022, then jumped by 153.5% to $1.2 million in 2023, then slumped by 74.2% to $308000.0 in 2024, then plunged by 47.73% to $161000.0 in 2025, then sank by 72.05% to $45000.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $45000.0, $161000.0, and $130000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.